Brittany Ngo

Brittany Ngo

Author Cites Persistent Tobacco Industry Attempts To Influence WHO

Thirteen years after publication of the landmark report, “Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization,” little has changed and industry manipulations continue, one of the lead authors has said.

Data From Clinical Trials Identify Gaps In Health R&D

Lower-income countries receive much less attention in terms of clinical trial research, according to a study published in this month’s World Health Organization (WHO) Bulletin. The study also underscored the value and importance the WHO International Clinical Trials Registry Platform (ICTRP) provides as a resource for evaluating the distribution of clinical trials around the world, and for providing information for future policy on health R&D.

Report Finds Positives, Weaknesses In US AIDS Relief Programme

A US report released this week found that the President’s Emergency Plan for AIDS Relief (PEPFAR) has helped to make antiretroviral drug supply chains more efficient and reliable, but still contains several weaknesses that need to be addressed.

World Health Assembly: IP Considerations Play Key Role In Final Outcomes

Wrapping up one day early, the 66th World Health Assembly adopted a range of public health resolutions and decisions, some with key intellectual property implications, including a decision to convene a technical meeting on new public health R&D projects, a compromise on advancing the poor quality medicines mechanism, and resolutions on both neglected tropical diseases and noncommunicable diseases. Importantly, the novel coronavirus situation drew attention to WHO’s progress in pandemic influenza preparedness.

World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System

The issue of access to medicines is on the agenda at this week’s World Health Assembly (WHA) and public health advocates are seeking greater clarity and detail about the latest member state effort to address failings in the global system of research and development for medical products.

Conference On Journalism And Health Looks At WHA Issues

On the eve of the 66th edition of the World Health Assembly, the World Health Editors Network (WHEN) and the Who’s There? Yes (WTY) convened for a conference on their new Journalism and Health Initiative. The conference, entitled, “Enter the stadium, democratise knowledge, bring it home,” focussed on increasing access and awareness of health policy and problems by the general public.